Skip to content

Characteristics of female patients with migraine attacks associated with sex hormone fluctuations

Characteristics of female patients with migraine attacks associated with sex hormone fluctuations - The WHAT! - Diary Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45933
Enrollment
500
Registered
2019-02-07
Start date
2019-02-18
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

headache migraine

Interventions

None listed

Sponsors

Neurologie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Female - At least 18 years of age - Migraine without aura, migraine with aura or chronic migraine (according to the International Classification of Headache Disorders ICHD-3b)

Exclusion criteria

Exclusion criteria: - Women who are pregnant or breastfeeding - Continuous combined oral contraceptive use and not willing to insert pill-free weeks during the study - Other continuous sex hormonal therapies (e.g. hormone-releasing intrauterine device, progesterone-only pill, Implanon NXT, Depo-Provera) - Spontaneous postmenopausal status (menstrual bleedings have ceased for 12 consecutive months) - History of unilateral or bilateral oophorectomy - History of hysterectomy - Current gynaecological malignancy

Design outcomes

Primary

MeasureTime frame
Migraine attack duration

Secondary

MeasureTime frame
Secondary study parameters: Clinical characteristics of migraine attacks: - Migraine attack severity - Migraine associated factors (photophobia, phonophobia, nausea, vomiting) - Aura symptoms - Efficacy of acute medication use: type and dosage - Migraine attack timing during menstrual cycle Hormone-related characteristics: - Menstrual cycle length - Premenstrual complaints based on Daily Record of Severity of Problems Tertiary study parameters: Clinical characteristics of migraine patients: - Migraine attack frequency per month - Number of migraine days per month - Number of headache days per month - Current prophylactic medication use: type and dosage - Current exogenous sex hormone use: type - Current climacteric symptoms based on Greene Climacteric Scale - Current premenstrual syndrome and/or premenstrual dysphoric disorder based on Daily Record of Severity of Problems - Current depression and anxiety symptoms based on HADS, CES-D, MASQ-30 - Menstrual cycle history - Obstetric history

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)